Research

Servier’s $1.55 billion muscular dystrophy drug fails first major test

STAT described the result as a setback for a drug being tested for a form of muscular dystrophy that lacks treatment.

Reported by 2 outlets Tuesday, November 3, 2026

A gloved hand using a pipette in a laboratory
Photo: Public domain

The original reports on this story are listed below.

Reporting on this story

    More top stories

    This Week in Medicine

    The week in medicine, in five minutes

    The most important medical news of the week, summarized for you and easy to read. Every Sunday, free.

    Free. No spam. Unsubscribe anytime.